Both backed by phase 3 clinical trial data
People just, you know, people are really, I think, nervous about the whole peptide world
The absence of back pain from official safety databases suggests it is not a direct pharmacological effect of the drug, but rather an indirect consequence of other changes happening during weight loss therapy
[DOI] [PubMed] [Google Scholar] 78.Chen M.L., Hong C.G., Yue T., Li H.M., Duan R., Hu W.B., Cao J., Wang Z.X., Chen C.Y., Hu X.K., et al
In early 2023, semaglutide also gained FDA approval to treat obesity in pediatric patients aged 12 years and older [6, 7]
At Victory Mens Health, we specialize in personalized treatment plans designed to match your lifestyle, needs, and goals